Martina Carlotti-Prochazkova

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Cutaneous diffuse large B-cell lymphoma induces a macrophage immunosuppressive phenotype through IL-10 secretion.

Cutaneous diffuse large B-cell lymphoma induces a macrophage immunosuppressive phenotype through IL-10 secretion.

Journal: Blood advances

Published: March 14, 2025

Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas.

Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas.

Journal: Genes

Published: December 20, 2022

Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.

Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.

Journal: The Journal of investigative dermatology

Published: July 05, 2022

Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas.

Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas.

Journal: Genes

Published: February 18, 2022

Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma.

Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma.

Journal: The Journal of investigative dermatology

Published: October 25, 2021

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.

Journal: Frontiers in oncology

Published: September 13, 2021

Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas.

Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas.

Journal: The Journal of investigative dermatology

Published: September 10, 2021

Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.

Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.

Journal: Molecular oncology

Published: September 26, 2020

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity.

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity.

Journal: Leukemia

Published: April 28, 2020

Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.

Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.

Journal: Molecular oncology

Published: December 24, 2019

Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.

Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.

Journal: The American journal of surgical pathology

Published: November 26, 2019

Reliable blood cancer cells' telomere length evaluation by qPCR.

Reliable blood cancer cells' telomere length evaluation by qPCR.

Journal: Cancer medicine

Published: May 03, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026